Presentations -
-
Therapeutic potential of cardiomyocyte-derived EVs in COVID-19-induced cardiac damage and fibrosis
[Domestic presentation]
2025.10,Oral presentation (general)
-
[International presentation]
2025.09,Oral presentation (general)
-
Therapeutic potential of cardiomyocyte-derived EVs in COVID-19-induced cardiac damage and fibrosis
[International presentation]
2025.07,Oral presentation (invited, special)
-
Cardiomyocytes-derived EVs for the treatment of cardiac fibrosis and cardiac damage
[International presentation] APSEV 2024,
2024.11,Oral presentation (keynote)
-
Cardiomyocytes-EVs improved COVID-19-derived cardiac damage and fibrosis
[Domestic presentation] JSEV 2024,
2024.10,Poster presentation
-
Cardiomyocytes-EVs improved COVID-19-derived cardiac damage and fibrosis
[Domestic presentation] GEIVEX 2024,
2024.10 -
Cardiomyocytes-derived EVs for the treatment of COVID-19-induced cardiac damage.
[International presentation]
2024.05,Poster presentation
-
Cardiomyocytes-derived EVs for the treatment of cardiac fibrosis and COVID-19-derived cardiac damage
[Domestic presentation] JSEV 2023,
2023.10,Oral presentation (general)
-
Adult cardiomyocytes-derived EVs for the treatment of cardiac fibrosis
[Domestic presentation] 第8回血管生物若手研究会,
2023.05,Oral presentation (general)
-
[International presentation] ISEV2023,
2023.05,Oral presentation (general)
-
Adult cardiomyocytes-derived EVs for the treatment of cardiac fibrosis. Invited speaker.
[International presentation] APSEV2023,
2023.03-2023.04,Symposium, workshop panel (public)
-
[International presentation] JCA 2022,
2022.09-2022.10,Poster presentation
-
Cardiomyocytes-derived EVs for the treatment of cardiac fibrosis and cardiac regeneration
[Domestic presentation] 32nd Forum in DOJIN. ,
2022.09,Public lecture, seminar, tutorial, course, or other speech
-
MiRNA-146a-5p Carried by Extracellular Vesicles Promotes Angiogenesis in High-Grade Bladder Cancer.
[Domestic presentation] 日本核酸医薬学会第7回年会,
2022.07-2022.08,Poster presentation
-
Adult cardiomyocytes-derived EVs for the treatment of cardiac fibrosis
[International presentation] ISEV 2022,
2022.05,Oral presentation (general)
-
Adult cardiomyocytes-derived EVs for the treatment of cardiac fibrosis
[Domestic presentation] 血管生物医学会若手研究会 2021,
2021.12,Oral presentation (general)
-
化合物刺激された心筋細胞由来エクソソームの心筋線維症に対する治療効果の検討
[Domestic presentation] 日本細胞外小胞学会 2021,
2021.10,Oral presentation (general)
-
[International presentation] JCA 2021,
2021.09-2021.10,Poster presentation
-
Chemically modified myocytes-derived EVs for the treatment of cardiac fibrosis.
[International presentation] ISEV 2021,
2021.05,Poster presentation